Manufacturer of Luspatercept

Luspatercept (Luspatercept) is an important drug developed and produced by Acceleron Pharma. This innovative drug represents a major advance in the field of biopharmaceuticals in the treatment of specific blood disorders, providing a new hope and treatment option for patients suffering from these diseases.

Acceleron Pharma is an American biopharmaceutical company headquartered in Cambridge, Massachusetts. The company focuses on developing biologics, which are typically manufactured through biotechnology methods such as genetic engineering and cell culture. Acceleron Pharma’s mission is to improve the quality of life for patients, especially those suffering from serious blood disorders, through scientific innovation.

The mechanism of action of Rotercept is very unique. It is a synthetic protein designed to mimic a protein in the body called activating TGF-beta superfamily receptors. Receptors from this family regulate red blood cell production and maturation in the body. When these receptors are activated, they inhibit the normal production of red blood cells, causing symptoms of anemia. By binding to these receptors, Rotercept regulates signaling pathways, thereby increasing the development and maturation of immature red blood cells and improving the quantity and quality of red blood cells. This process helps improve patients' anemia symptoms and enhances the ability to deliver oxygen to all parts of the body.

The drug is already approved to treat certain blood disorders such as aplastic anemia (β-thalassemia) and myelodysplastic syndrome (MDS) that are highly transfusion-dependent. Patients usually need to receive frequent blood transfusions, but the use of Rotacept can significantly reduce dependence on blood transfusions and improve patients' quality of life.

Rotexip is already on the market in China and has been included in medical insurance. Patients can purchase it domestically. Please consult the local hospital pharmacy for specific prices. There are only original drugs for Rotesip abroad, mainly European ones, with a price of more than 10,000 yuan.